The goal of this study was to characterize extracellular vesicles (EVs) and miRNAs of 
Introduction

31
The cervicovaginal canal is a potential source of biological markers for forensics investigations Total RNA was eluted with 50 µL RNase-free water and stored at -80°C. As quality control,
5
A custom 48-feature TaqMan low-density array (TLDA) was ordered from Thermo Fisher, with 178 features chosen based on results of a human CVL pilot study (GVH and KWW, unpublished data) .
179
Stem-loop primer reverse transcription and pre-amplification steps were conducted using the 180 manufacturer's reagents as previously described 46 
184
by a factor determined from the geometric mean of 10 relatively invariant miRNAs. The selection 185 process for these invariant miRNAs was to 1) rank miRNAs by coefficient of variation; 2) remove 186 miRNAs with high average Cq (>30), non-miRNAs, and those with low amplification score; 3) select 187 the lowest-CV member of miRNA families (e.g., the 17/92 clusters); and 4) pick the top 10 remaining 188 candidates by 189 and -320a-3p.
191
Individual RT-qPCR Assays
192
Individual TaqMan miRNA qPCR assays were performed as previously described 46 
209
PBMC fractions were removed, washed in PBS+ 2% FBS, and pelleted at 300 × g for 8 minutes. Pellets 210 from 5 tubes were combined by resuspension in 10 mL RBC lysis buffer (4.15 g NH # Cl, 0.5 g KHCO ( , 211 0.15 g EDTA in 450 mL H ) O; pH adjusted to 7.2-7.3; volume adjusted to 500 mL and filter-sterilized); 212 total volume was brought to 40 mL with RBC lysis buffer. After incubation at 37 °C for 5 mins, the 213 suspension was centrifuged at 400 × g for 6 mins at room temperature. 
281
Plasma and CVL were collected from two control and four SIV-infected macaques over the 282 course of five weeks (Supplemental Figure 1) . Abnormal cycling was observed for infected subjects
283
(K. Mulka, et al, unpublished data) . By nanoparticle tracking analysis, CVL EV concentration in 284 control animals increased during ovulation ( Figure 1A ). Transmission electron microscopy was 285 performed for representative fractions of CVL, revealing bacteria and large particles in the 10,000 × g 286 pellet ( Figure 1B ). The 100,000 x g pellet included apparent EVs up to 200 nm in diameter ( Figure 1C ).
287
EV markers (shown: CD63, CD81, and TSG101) were confirmed by Western blot ( Figure 1D ). The 288 nuclear marker nucleoporin was detected only in tissue samples ( Figure 1D ). 
309
was fractionated by stepped centrifugation to yield a 10,000 x g pellet (10K pellet), a 100,000 x g pellet
310
(UC pellet), and 100,000 x g supernatant (UC supernatant). Total RNA from all fractions was profiled 311 by TLDA. Raw (Supplemental Figure S2A ), quantile normalized (Supplemental Figure S2B) , and geometric mean-adjusted Cq values (Supplemental Figure S2C ) were subjected to unsupervised 313 hierarchical clustering. This clustering did not reveal broad miRNA profile differences associated 314 with sample collection time, menstruation, or SIV infection.
315
Distribution of miRNAs across CVL fractions
316
Across the three examined CVL fractions (p10, p100, S100), the ten most abundant miRNAs
317
(lowest Cq values) were miRs-223-3p, -203a-3p, -24-3p, -150-5p, -21-5p, -146a-5p, -92a-3p, -222-3p, -
318
17-5p, and -106a-5p. The average normalized Cq value for each miRNA was greater (i.e., lower 319 abundance) in the p100 than the s100 fraction ( Figure 2A and inset), and indeed in p10 and p100 320 combined ( Figure 3B ), suggesting that most miRNA in CVL, as reported for various other body fluids,
321
is found outside the EV-enriched fractions. Considering all fractions, the differences between the EV-
322
enriched and EV-depleted fractions were significant even after Bonferroni correction for all features 323 except U6. On average, the s100 fraction contained 86.5% of the total miRNA from these three 324 fractions. In the p10 fraction, the average miRNA was detected at 10.5% its level in the s100 fraction
325
(SD=5.7%). miR-34a-5p had the lowest (5.9%) and miR-28-3p the highest (33.7%) abundance 326 compared with s100. In the p100 fraction, miRNAs were on average 5.6% (SD=2.4%) as abundant as 327 in s100. The least represented in p100 was miR-27a-3p (2.3%), and the best represented was again 328 miR-28-3p (13.4%). Together, the content of the EV-enriched fractions (p10 and p100) as a percentage
329
of the total is shown in Figure 2B for individual miRNAs. miRNA rank was significantly correlated 
336
Cq) in ascending order, from miR-27a-3p (7.9%) to miR-28-3p (32.0%). C) miRNAs in each fraction
337
(10,000× g pellet=p10, 110,000 × g pellet=p100, 110,000× g supernatant=S100, and) are significantly 338 correlated (p<0.0001, Spearman).
339
qPCR Validation
340
Individual stem loop RT/hydrolysis probe qPCR assays were used to verify TLDA results for 341 eleven selected miRNAs plus miR-375-3p (not included on the array), which was also measured 342 because of a reported association with goblet cells 49 . Some miRNAs were chosen due to high 343 expression levels. miR-181a-5p was measured due to its association with endometrial cells 50, 51 . miR-
344
125b-5p has been reported as a diagnostic marker of endometriosis 52 . Other miRNAs (miRs-186-5p, -451a-5p, -200c-3p, -222-3p, -193b-3p) were selected based on our previous experience and results
345
346
from other studies evaluating miRNAs in the context of HIV-1 and SIV infections. Results of qPCR 347 assays, adjusted by miR-16-5p for each sample (since we found relatively low qPCR variation of miR-
348
16-5p, a commonly used normalizer 53 ), are shown in Figure 3A . Figure 3B compares miRNA ranks
349
(1-11) by TLDA and individual qPCR, which are generally in concordance. Note that expression of 350 red blood cell miRNA miR-451a-5p was low, suggesting minimal contamination from blood for most 
386
However, at the same time points and also out to nine days post-infection, a different result was 387 seen for capsid p24 release into the supernatant. For infected but untransfected cells, measurable p24 388 was observed by 3 dpi, and p24 counts increased by two-fold or more by 9 dpi ( Figure 6A 
416
which increased miR-186-5p levels from around 5-fold to nearly 500-fold, respectively. Strikingly,
417
the miR-186-5p level was inversely correlated with released p24 across these five donors. It should
418
be noted that miR-186-5p antisense inhibitors were also introduced in these experiments. While they did not significantly increase HIV p24 release (Figure 7 ), they also did not achieve a consistent 420 knockdown of native miR-186-5p ( Figure 8A ). Control 1 1 mL 2 mL 1 mL 1 mL 1 mL Control 2 3 mL 0.7 mL 2 mL 0.5 mL 1.25 mL Infected 1 1 mL 0.2 mL 0.5 mL 0.3 mL 1.5 mL Infected 2 1.5 mL 1.5 mL 2 mL 0.8 mL 1.75 mL Infected 3 0.5 mL 0.6 mL 2.8 mL 0.8 mL 2 mL Infected 4 0.8 mL 0.3 mL 0.6 mL 0.3 mL 1.5 mL 818 819 
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